Stericycle (SRCL) Gets a Hold from Truist Financial
TipRanks (Tue, 28-May 7:36 AM ET)
Stericycle President and CEO Cindy J. Miller Receives 2024 Women Who Inspire Award From Waste360
PRNewswire (Wed, 8-May 7:00 AM ET)
Stericycle to Participate in Oppenheimer 19th Annual Industrial Growth Conference in May
Globe Newswire (Tue, 30-Apr 6:00 PM ET)
Stericycle to Participate in Stifel 2024 Investor Summit at WasteExpo in May
Globe Newswire (Tue, 30-Apr 6:00 PM ET)
Stericycle, Inc. Reports Results For The First Quarter 2024
Globe Newswire (Thu, 25-Apr 7:00 AM ET)
Stericycle Receives a B Rating on Third CDP Climate Change Survey
PRNewswire (Mon, 1-Apr 7:00 AM ET)
PRNewswire (Tue, 26-Mar 7:00 AM ET)
Stericycle is the largest provider of medical waste disposal and data destruction (primarily paper shredding) services in the United States. Its next-closest national competitor in medical waste disposal is Sharps Compliance, which generated $76 million of sales in fiscal 2021 before its 2022 acquisition (about 4% of Stericycle's global regulated waste and compliance revenue). Stericycle's data destruction business, Shred-It, is about twice the size of its closest competitor (Iron Mountain's information destruction segment). Stericycle has a global presence, with about 20% of its revenue earned outside North America.
Stericycle trades on the NASDAQ stock market under the symbol SRCL.
As of May 30, 2024, SRCL stock price declined to $49.09 with 229,524 million shares trading.
SRCL has a beta of 0.79, meaning it tends to be less sensitive to market movements. SRCL has a correlation of 0.13 to the broad based SPY ETF.
SRCL has a market cap of $4.55 billion. This is considered a Mid Cap stock.
Last quarter Stericycle reported $665 million in Revenue and $.57 earnings per share. This fell short of revenue expectation by $-12 million and exceeded earnings estimates by $.01.
In the last 3 years, SRCL stock traded as high as $79.23 and as low as $37.78.
The top ETF exchange traded funds that SRCL belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
SRCL has underperformed the market in the last year with a return of +13.9%, while the SPY ETF gained +26.6%. In the last 3 month period, SRCL fell short of the market, returning -9.7%, while SPY returned +3.6%. However, in the most recent 2 weeks SRCL has outperformed the stock market by returning +5.5%, while SPY returned -0.9%.
SRCL support price is $48.61 and resistance is $50.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SRCL stock will trade within this expected range on the day.